Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 14, 2006

Articles

Favourites:
ADD

Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
pp. 1683-1702(20)
Authors: Werry, Tim D.; Christopoulos, Arthur; Sexton, Patrick M.

Favourites:
ADD

Integrative Functional Assays, Chemical Genomics and High Throughput Screening: Harnessing Signal Transduction Pathways to a Common HTS Readout
pp. 1717-1729(13)
Authors: Burstein, Ethan S.; Piu, Fabrice; Ma, Jian-Nong; Weissman, Jacques T.; Currier, Erika A.; Nash, Norman R.; Weiner, David M.; Spalding, Tracy A.; Schiffer, Hans H.; Del Tredici, Andria L.; Brann, Mark R.

Favourites:
ADD

Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
pp. 1731-1750(20)
Authors: Estall, J. L.; Drucker, D. J.

Favourites:
ADD

Cannabinoid Receptors as Therapeutic Targets
pp. 1751-1769(19)
Authors: Pavlopoulos, Spiro; Thakur, Ganesh A.; Nikas, Spyros P.; Makriyannis, Alexandros

Favourites:
ADD
Favourites:
ADD

Screening the Receptorome Yields Validated Molecular Targets for Drug Discovery
pp. 1785-1795(11)
Authors: Roth, Bryan L.; Kroeze, Wesley K.

Favourites:
ADD

Co-Ordinated Covalent Modification of G-Protein Coupled Receptors
pp. 1797-1808(12)
Authors: Torrecilla, Ignacio; Tobin, Andrew B.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content